Submit an Article
Navigate
Home
Editorial Board
Editorial Policies
Current Volume
Archive
Scientific Integrity
Publication Ethics Statements
Interviews with Outstanding Authors
Newsroom
Sponsored Conferences
Podcast
Contact
Special Collections
Submit an Article
Online ISSN: 1945-4589
Research Paper
|
Volume 13, Issue 6
|
pp. 8975–8988
PARP inhibitors in breast and ovarian cancer with BRCA mutations: a meta-analysis of survival
Back to article
Figure 4
(4 of 5)
−
100%
+
Figure 4.
Efficacy of each PARPi in breast and ovarian cancer patients with BRCAm.
